Company intelligence / Profile preview

LOFT

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Loft Bio is a biotechnology company focused on developing a platform for the next generation of programmable genetic medicines. The company's technology aims to enable the precise design and delivery of complex genetic payloads to treat a variety of diseases. By leveraging advanced delivery systems and programmable molecular architectures, Loft Bio seeks to overcome current limitations in gene therapy and mRNA-based treatments. The company is currently in the early stages of development, building out its core platform and initial pipeline programs.

Modalities: mRNA-based drugsLipid nanoparticle delivery therapyGene therapy
Industry: Biotech

Beyond the preview

Go deeper on LOFT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LOFT.

Explore the full profile